ADPT

Adaptive Biotechnologies Corporation

Halal Rating :
Uncomfortable
See Details
Last Price $5.07 Last updated:
Market Cap $693.12m
7D Change -12.89%
1 Year Change 25.81%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange NASDAQ
Next Earnings Date Nov. 7, 2024

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $46.44m $82.01m - $2.94m 0.00% 3.58%
June 30, 2024 $43.19m $93.2m - $2.7m 0.00% 2.89%
March 31, 2024 $41.87m $93.63m - $2.99m 0.00% 3.20%

Company Impact

Help us evaluate Adaptive Biotechnologies Corporation's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Justification for our Halal Rating

Contribute

Recent News & Updates